BIAF bioAffinity Technologies Inc Forecast, Technical & Fundamental Analysis
bioAffinity Technologies Inc develops noninvasive diagnostic laboratory tests to detect early-stage lung cancer and other diseases of the lung using flow cytometry and automated analysis informed by machine learning, a form of artificial intelligence (AI)... Show more
BIAF is expected to report earnings to rise 159.26% to -209 cents per share on August 19
Q2'26
Est.
$-2.10
Q1'26
Missed
by $0.73
Q4'25
Missed
by $0.61
Q3'25
Missed
by $4.65
Q2'25
Missed
by $0.07
The last earnings report on May 08 showed earnings per share of -81 cents, missing the estimate of -8 cents. With 276.70K shares outstanding, the current market capitalization sits at 4.38M.
A.I.dvisor tells us that BIAF and SNWV have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIAF and SNWV's prices will move in lockstep.
BIAF in upward trend: price may jump up because it broke its lower Bollinger Band on July 08, 2026
BIAF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 26 cases where BIAF's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 17 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 54 cases where BIAF's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BIAF just turned positive on July 02, 2026. Looking at past instances where BIAF's MACD turned positive, the stock continued to rise in of 33 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIAF advanced for three days, in of 138 cases, the price rose further within the following month. The odds of a continued upward trend are .
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on July 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BIAF as a result. In of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where BIAF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for BIAF entered a downward trend on July 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.196) is normal, around the industry mean (12.988). P/E Ratio (0.000) is within average values for comparable stocks, (150.755). BIAF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.632). BIAF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.008). P/S Ratio (0.337) is also within normal values, averaging (7.587).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. BIAF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BIAF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
